Skip to main content

Aclarion Inc

For the period ended Mar 31, 2024. Filed May 15, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 15, 2024

ACON$1.75+5.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Changes in Stockholders' Equity

Condensed Statements of Changes in Stockholders' Equity (Deficit)

Series A · Series A-1, A-2, A-3, A-4 · Series B, B-1 · Series B-2, B-3
Preferred Stock · Preferred Stock · Preferred Stock · Preferred Stock
SharesValueSharesValueSharesValueSharesValue*
Balance, December 31, 2022–$––$––$––$–
Share-based compensation––––––––
Proceeds from sale of Series A preferred stock11,000––––––
Redemption of Series A Preferred stock(1)(1,000)––––––
Net income (loss)––––––––
Balance, March 31, 2023–$––$––$––$–
For the Three Months Ended March 31, 2024
Balance, December 31, 2023–$––$––$––$–
Share-based compensation––––––––
Issuance of common stock and warrants related to public offering, net issuance costs––––––––
Issuance of common shares - equity line––––––––
Public offering and equity line issuance costs––––––––
Issuance of common shares - debt for equity exchange––––––––
Issuance of commitment shares - note financing––––––––
Issuance of common shares related to restricted stock units––––––––
Cashless exercise of pre-funded warrants––––––––
Round up convention related to reverse stock split––––––––
Net income (loss)––––––––
Balance, March 31, 2024–$––$––$––$–

(continued)

Condensed Statements of Changes in Stockholders' Equity (Deficit)

(continued)

For the Three Months Ended March 31, 2023
Additional
Common Stock · Paid-In · Accumulated
SharesValueCapitalDeficitTotal
Balance, December 31, 2022491,345$5$41,596,106$(39,370,153)$2,225,958
Share-based compensation––82,531–82,531
Proceeds from sale of Series A preferred stock––––1,000
Redemption of Series A Preferred stock––––(1,000)
Net income (loss)–––(1,183,460)(1,183,460)
Balance, March 31, 2023491,345$5$41,678,637$(40,553,613)$1,125,029
Balance, December 31, 2023825,459$8$43,553,523$(44,281,526)$(727,995)
Share-based compensation––85,827–85,827
Issuance of common stock and warrants related to public offering, net issuance costs5,175,000522,691,339–2,691,391
Issuance of common shares - equity line452,34351,449,527–1,449,532
Public offering and equity line issuance costs––(399,106)–(399,106)
Issuance of common shares - debt for equity exchange644,14261,771,600–1,771,606
Issuance of commitment shares - note financing9,312–33,297–33,297
Issuance of common shares related to restricted stock units4,261––––
Cashless exercise of pre-funded warrants2,915––––
Round up convention related to reverse stock split40,068––––
Net income (loss)–––(2,399,102)(2,399,102)
Balance, March 31, 20247,153,500$72$49,186,006$(46,680,628)$2,505,450
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.